TY  - GEN
AU  - Wang,Zhao
AU  - Fang,Xiaojie
AU  - Huang,He
AU  - Hong,Huangming
AU  - Li,Xueying
AU  - Guo,Chengcheng
AU  - Fu,Xiaohong
AU  - Zhang,Mengping
AU  - Lam,Sio Teng
AU  - Li,Shanshan
AU  - Li,Fangfang
AU  - Peng,Chen
AU  - Tian,Ying
AU  - Lin,Tongyu
TI  - Recombinant human thrombopoietin (rh-TPO) for the prevention of severe thrombocytopenia induced by high-dose cytarabine: a prospective, randomized, self-controlled study
SN  - 1029-2403
PY  - 2019///0624
KW  - Adult
KW  - Aged
KW  - Antimetabolites, Antineoplastic
KW  - administration & dosage
KW  - Cytarabine
KW  - Dose-Response Relationship, Drug
KW  - Drug Administration Schedule
KW  - Female
KW  - Humans
KW  - Lymphoma, Non-Hodgkin
KW  - blood
KW  - Male
KW  - Middle Aged
KW  - Platelet Count
KW  - Platelet Transfusion
KW  - statistics & numerical data
KW  - Prospective Studies
KW  - Recombinant Proteins
KW  - Thrombocytopenia
KW  - Thrombopoietin
KW  - Treatment Outcome
KW  - Young Adult
N1  - Publication Type: Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial
UR  - https://doi.org/10.1080/10428194.2018.1459605
ER  -